Literature DB >> 14216086

PATHOLOGICAL FIBRINOLYSIS.

A A SHARP.   

Abstract

Keywords:  AMINOCAPROIC ACID; ANTICOAGULANTS; BLOOD COAGULATION DISORDERS; BLOOD GROUP INCOMPATIBILITY; DRUG THERAPY; FIBRINOGEN; FIBRINOLYSIS; HEART, MECHANICAL; HEMATOMA, SUBDURAL; LEUKEMIA; LIVER CIRRHOSIS; MENORRHAGIA; PERITONEUM; PLEURA; POSTOPERATIVE COMPLICATIONS; PREGNANCY; PREGNANCY COMPLICATIONS; PROSTATIC NEOPLASMS; REVIEW; SNAKE BITES; STREPTODORNASE AND STREPTOKINASE; THROMBOPENIA; UROGENITAL SYSTEM; WOUNDS AND INJURIES

Mesh：

Substances：

Year:  1964        PMID： 14216086     DOI： 10.1093/oxfordjournals.bmb.a070339

Source DB:  PubMed          Journal:  Br Med Bull        ISSN： 0007-1420            Impact factor:   4.291


× No keyword cloud information.
  5 in total

1.  Assessment of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in Breast Cancer Tissue: Historical Aspects and Future Prospects.

Authors:  Manfred Schmitt; Karin Mengele; Apostolos Gkazepis; Rudolf Napieralski; Viktor Magdolen; Ute Reuning; Nadia Harbeck
Journal:  Breast Care (Basel)       Date:  2008-10-15       Impact factor: 2.860

Review 2.  A risk-benefit assessment of aprotinin in cardiac surgical procedures.

Authors:  W B Dobkowski; J M Murkin
Journal:  Drug Saf       Date:  1998-01       Impact factor: 5.606

Review 3.  Is there a place for proteinase inhibition? A review of the literature.

Authors:  G D Lister
Journal:  Postgrad Med J       Date:  1969-08       Impact factor: 2.401

4.  [Studies of blood coagulation disorders following thoracic surgery. A contribution to the problem of postoperative thrombosis and embolism impendence].

Authors:  D Wülfing; H Egli; H Kalinke
Journal:  Langenbecks Arch Chir       Date:  1968

Review 5.  Clinical application of inhibitors of fibrinolysis.

Authors:  M Verstraete
Journal:  Drugs       Date:  1985-03       Impact factor: 9.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.